Critical roles of protein methyltransferases and demethylases in the regulation of embryonic stem cell fate

由 Vougiouklakis, Theodore, Nakamura, Yusuke, Saloura, Vassiliki
發表在 Epigenetics (2018)

Protein methyltransferases and demethylases dictate CD8+ T-cell exclusion in squamous cell carcinoma of the head and neck

由 Vougiouklakis, Theodore, Bao, Riyue, Nakamura, Yusuke, Saloura, Vassiliki
發表在 Oncotarget (2017)

SMYD3: a regulator of epigenetic and signaling pathways in cancer

由 Bernard, Benjamin J., Nigam, Nupur, Burkitt, Kyunghee, Saloura, Vassiliki
發表在 Clin Epigenetics (2021)

Epigenetic modulation of immunotherapy and implications in head and neck cancer

由 Zhou, Liye, Xu, Na, Shibata, Hirofumi, Saloura, Vassiliki, Uppaluri, Ravindra
發表在 Cancer Metastasis Rev (2021)

Clinicopathologic significance of protein lysine methyltransferases in cancer

由 Vougiouklakis, Theodore, Bernard, Benjamin J., Nigam, Nupur, Burkitt, Kyunghee, Nakamura, Yusuke, Saloura, Vassiliki
發表在 Clin Epigenetics (2020)

Corrigendum to “The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck” [Oral Oncol. 81 (2018) 100–108]

由 Saloura, Vassiliki, Vougiouklakis, Theodore, Burkitt, Kyunghee, Nakamura, Yusuke, Hager, Gordon L., van Waes, Carter
發表在 Oral Oncol (2018)

Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX

由 Vougiouklakis, Theodore, Saloura, Vassiliki, Park, Jae-Hyun, Takamatsu, Naofumi, Miyamoto, Takashi, Nakamura, Yusuke, Matsuo, Yo
發表在 Oncotarget (2018)

The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck

由 Saloura, Vassiliki, Vougiouklakis, Theodore, Sievers, Cem, Burkitt, Kyunghee, Nakamura, Yusuke, Hager, Gordon, van Waes, Carter
發表在 Oral Oncol (2018)

SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells

由 Vougiouklakis, Theodore, Sone, Kenbun, Saloura, Vassiliki, Cho, Hyun-Soo, Suzuki, Takehiro, Dohmae, Naoshi, Alachkar, Houda, Nakamura, Yusuke, Hamamoto, Ryuji
發表在 Oncotarget (2015)

p53-independent p21 induction by MELK inhibition

由 Matsuda, Tatsuo, Kato, Taigo, Kiyotani, Kazuma, Tarhan, Yunus Emre, Saloura, Vassiliki, Chung, Suyoun, Ueda, Koji, Nakamura, Yusuke, Park, Jae-Hyun
發表在 Oncotarget (2017)

WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck

由 Saloura, Vassiliki, Vougiouklakis, Theodore, Zewde, Makda, Kiyotani, Kazuma, Park, Jae-Hyun, Gao, Guimin, Karrison, Theodore, Lingen, Mark, Nakamura, Yusuke, Hamamoto, Ryuji
發表在 Oncotarget (2016)

A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer

由 Brisson, Ryan J., Kochanny, Sara, Arshad, Saba, Dekker, Allison, DeSouza, Jonas A., Saloura, Vassiliki, Vokes, Everett E., Seiwert, Tanguy Y.
發表在 Head Neck (2019)

The Oncogenic Polycomb Histone Methyltransferase EZH2 Methylates Lysine 120 on Histone H2B and Competes Ubiquitination

由 Kogure, Masaharu, Takawa, Masashi, Saloura, Vassiliki, Sone, Kenbun, Piao, Lianhua, Ueda, Koji, Ibrahim, Reem, Tsunoda, Tatsuhiko, Sugiyama, Masanori, Atomi, Yutaka, Nakamura, Yusuke, Hamamoto, Ryuji
出版 2013

WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer

由 Saloura, Vassiliki, Vougiouklakis, Theodore, Zewde, Makda, Deng, Xiaolan, Kiyotani, Kazuma, Park, Jae-Hyun, Matsuo, Yo, Lingen, Mark, Suzuki, Takehiro, Dohmae, Naoshi, Hamamoto, Ryuji, Nakamura, Yusuke
發表在 Sci Rep (2017)

WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck

由 Saloura, Vassiliki, Vougiouklakis, Theodore, Bao, Riyue, Kim, Sohyoung, Baek, Songjoon, Zewde, Makda, Bernard, Benjamin, Burkitt, Kyunghee, Nigam, Nupur, Izumchenko, Evgeny, Dohmae, Naoshi, Hamamoto, Ryuji, Nakamura, Yusuke
發表在 Neoplasia (2020)

Expression of Interferon-β Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma

由 Willmon, Candice L., Saloura, Vassiliki, Fridlender, Zvi G., Wongthida, Phonphimon, Diaz, Rosa Maria, Thompson, Jill, Kottke, Timothy, Federspiel, Mark, Barber, Glen, Albelda, Steven M., Vile, Richard G.
出版 2009

Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma

由 Ren, Lili, Leisegang, Matthias, Deng, Boya, Matsuda, Tatsuo, Kiyotani, Kazuma, Kato, Taigo, Harada, Makiko, Park, Jae-Hyun, Saloura, Vassiliki, Seiwert, Tanguy, Vokes, Everett, Agrawal, Nishant, Nakamura, Yusuke
發表在 Oncoimmunology (2019)

Ex Vivo Antibody-Dependent Cellular Cytotoxicity Inducibility Predicts Efdicacy of Cetuximab

由 Taylor, Rodney J., Saloura, Vassiliki, Jain, Ajay, Goloubeva, Olga, Wong, Stuart, Kronsberg, Shari, Nagilla, Madhavi, Silpino, Lorna, de Souza, Jonas, Seiwert, Tanguy, Vokes, Everett, Villaflor, Victoria, Cohen, Ezra E.W.
發表在 Cancer Immunol Res (2015)

Thymidylate Synthase and Folyl-polyglutamate synthase (FPGS) Are Not Clinically Useful Markers of Response to Pemetrexed [Pem] in Patients with Malignant Pleural Mesothelioma [MPM]

由 Schwed Lustgarten, Daniel E., Deshpande, Charuhas, Aggarwal, Charu, Wang, Liang-Chuan, Saloura, Vassiliki, Vachani, Anil, Wang, Li-Ping, Litzky, Leslie, Feldman, Michael, Creaney, Jeanette, Nowak, Anna K., Langer, Corey, Inghilleri, Simona, Stella, Giulia, Albelda, Steven M.
出版 2013

Evaluation of an Attenuated Vesicular Stomatitis Virus Vector Expressing Interferon-β for Use in Malignant Pleural Mesothelioma: Heterogeneity in Interferon Responsiveness Defines...

由 Saloura, Vassiliki, Wang, Liang-Chuan S., Fridlender, Zvi G., Sun, Jing, Cheng, Guanjun, Kapoor, Veena, Sterman, Daniel H., Harty, Ronald N., Okumura, Atsushi, Barber, Glen N., Vile, Richard G., Federspiel, Mark J., Russell, Stephen J., Litzky, Leslie, Albelda, Steven M.
出版 2010